from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3337/-

LFCtreatmentdescriptionclass of inhibitor

0.193

Amikacinug/mL Amikacintranslation

0.362

Cap5-10ug/mL Capreomycintranslation

0.111

Rox10-50 ug/mL Roxithromycintranslation

-0.056

SM2-5 ug/mL Streptomycintranslation

0.659

Tet5-10 ug/mL Tetracyclinetranslation

0.035

Rif0.2-5ug/mL Rifampicintranscription

-0.560

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.841

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.027

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.570

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.163

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.356

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.813

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.433

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.188

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.222

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.555

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.690

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.260

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.060

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.892

KCN5-20 ug/mL Potassium cyaniderespiration

-0.647

NaN30.2-2 mM Sodium aziderespiration

-0.129

Nigericin50 uM Nigericinrespiration

0.108

TRC10-150 ug/mL Triclosanrespiration

0.890

TRZ10-25 ug/mL Thioridazinerespiration

0.929

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.255

menadione6-10 ug/mL Menadionerespiration

3.357

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.209

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.200

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.048

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.625

NRP_1Non-replicating persistence stage 1dosRassociated

-0.428

Amp0.2mg/mL AmpicillincellWall

-0.145

Cephalexin20-100 ug/mL CephalexincellWall

-0.806

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.360

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.358

EMB10-20 ug/mL EthambutolcellWall

1.342

Eta12-40 ug/mL EthionamidecellWall

1.995

INH0.2-0.4 ug/mL IsoniazidcellWall

0.936

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.581

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.511

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.530

BZA0.12 mg/mL BenzamidearomaticAmides

-0.559

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.609

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.019

H2O24 mM hydrogen peroxideDNAdamaging

-0.556

Levo10 ug/mL LevofloxacinDNAdamaging

-0.776

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.662

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.392

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.020

UVUV-irradiationDNAdamaging

-0.432

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.227

Antimycin12.5-50 ug/mL Antimycin A?

-0.480

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.152

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.249

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.162

PA8240.2-2 ug/mL PA-824?

1.146

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.462

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.012

Verapamil50 uM Verapamil?

-0.508

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.955

methoxatin10-20 ug/mL Methoxatin?